Options

Gevo, Inc. Announces Closing of $18.0 Million Upsized Public Offering

Monday, July 6, 2020 - 10:40pm

Each share of common stock (or common stock equivalent) was sold in the offering with one warrant to purchase one share of common stock.

Key Points: 
  • Each share of common stock (or common stock equivalent) was sold in the offering with one warrant to purchase one share of common stock.
  • H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
  • The gross proceeds of the offering were $18.0 million, prior to deducting placement agents fees and other offering expenses payable by Gevo and assuming none of the warrants issued in the offering are exercised for cash.
  • Gevo intends to use the net proceeds from the offering for general corporate purposes.

CORRECTION: Aditx Therapeutics, Inc. (Aditxt) Announces Closing of Initial Public Offering

Monday, July 6, 2020 - 9:46pm

The number of Series A warrants and Series B warrants purchased by the underwriters in the over-allotment option has been corrected to 128,328.

Key Points: 
  • The number of Series A warrants and Series B warrants purchased by the underwriters in the over-allotment option has been corrected to 128,328.
  • The Series A warrants permit the holder to purchase one share of common stock at an exercise price of $9.00 and expire after 5 years.
  • The Companys common stock began trading on the Nasdaq Capital Market under the ticker symbol ADTX on June 30, 2020.
  • Sheppard, Mullin, Richter, & Hampton LLP acted as counsel to the Company in the offering.

Namaste Completes TSX Venture Filing For Option Grants

Friday, July 3, 2020 - 10:00pm

The options have a term of four years and will expire on July 2, 2024.

Key Points: 
  • The options have a term of four years and will expire on July 2, 2024.
  • In addition, the Board approved other option grants pursuant to agreed long term incentive plans.
  • Option grants are subject to approval of the TSX Venture Exchange.
  • and around the globe, Namaste Technologies is a leading online platform for cannabis products, accessories, and responsible education.

Pressure Technologies plc Disposes of Equity Securities of Greenlane Renewables Inc.

Friday, July 3, 2020 - 10:00pm

VANCOUVER, British Columbia, July 03, 2020 (GLOBE NEWSWIRE) -- Pressure Technologies plc ("Pressure Technologies") announced today that, through a series of trades on July 2, 2020, it has disposed of ownership and control of 7,663,920 common shares ("Greenlane Shares") in the capital of Greenlane Renewables Inc. ("Greenlane") and 5,094,765 warrants to purchase Greenlane Shares ("Warrants", and together with the Greenlane Shares, the "PT Securities"), upon exercise thereof, representing approximately 8.36% of the issued and outstanding Greenlane Shares on an undiluted basis and approximately 13.18% on a partially diluted basis (assuming the exercise of the Warrants only).

Key Points: 
  • VANCOUVER, British Columbia, July 03, 2020 (GLOBE NEWSWIRE) -- Pressure Technologies plc ("Pressure Technologies") announced today that, through a series of trades on July 2, 2020, it has disposed of ownership and control of 7,663,920 common shares ("Greenlane Shares") in the capital of Greenlane Renewables Inc. ("Greenlane") and 5,094,765 warrants to purchase Greenlane Shares ("Warrants", and together with the Greenlane Shares, the "PT Securities"), upon exercise thereof, representing approximately 8.36% of the issued and outstanding Greenlane Shares on an undiluted basis and approximately 13.18% on a partially diluted basis (assuming the exercise of the Warrants only).
  • The disposition was made following the execution a framework agreement dated as of July 2, 2020 with Greenlane, Creation Partners LLP and Brad Douville, which permitted Pressure Technologies to sell the PT Securities by amending and terminating certain contractual arrangements affecting such securities.
  • Pressure Technologies is issuing this press release pursuant to the requirements of National Instrument 62-103.
  • A copy of the related early warning report (the "Report") will be issued by Pressure Technologies and will be filed on the SEDAR website (www.sedar.com) under the profile for Greenlane Renewables Inc. For further information or to obtain a copy of the Report, please contact Pressure Technologies as follows:

Baudax Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Friday, July 3, 2020 - 8:25pm

The equity awards were granted pursuant to the NASDAQ Rule 5635(c)(4) inducement grant exception as a component of each individuals employment compensation and were granted as an inducement material to his or her acceptance of employment with Baudax Bio.

Key Points: 
  • The equity awards were granted pursuant to the NASDAQ Rule 5635(c)(4) inducement grant exception as a component of each individuals employment compensation and were granted as an inducement material to his or her acceptance of employment with Baudax Bio.
  • The options have an exercise price equal to $4.15 per share, the closing price of Baudax Bios common stock as reported by NASDAQ on June 30, 2020.
  • The equity awards are subject to each individuals continued service with Baudax Bio through the applicable vesting dates.
  • Baudax Bio is a specialty pharmaceutical company focused on therapeutics for acute care settings.

Aditx Therapeutics, Inc. (Aditxt) Announces Closing of Initial Public Offering

Thursday, July 2, 2020 - 9:10pm

The underwriters continue to hold a 45-day option to purchase up to an additional 184,000 shares of common stock at the public offering price, less underwriting discounts and commissions, to cover over-allotments, if any.

Key Points: 
  • The underwriters continue to hold a 45-day option to purchase up to an additional 184,000 shares of common stock at the public offering price, less underwriting discounts and commissions, to cover over-allotments, if any.
  • The common stock and the accompanying warrants included in the units were purchased together in this offering but were issued separately and were immediately separable upon issuance.
  • The Companys common stock began trading on the Nasdaq Capital Market under the ticker symbol ADTX on June 30, 2020.
  • Sheppard, Mullin, Richter, & Hampton LLP served as counsel to the Company in this offering.

Zomedica Pharmaceuticals Corp. Announces Proposed Public Offering

Wednesday, July 1, 2020 - 9:04pm

ANN ARBOR, Mich., July 01, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM), (Zomedica or the Company), a veterinary diagnostic company, announced today that it has commenced a public offering of its common shares, together with warrants to purchase its common shares.

Key Points: 
  • ANN ARBOR, Mich., July 01, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM), (Zomedica or the Company), a veterinary diagnostic company, announced today that it has commenced a public offering of its common shares, together with warrants to purchase its common shares.
  • All of the common shares and warrants in the offering will be sold by Zomedica.
  • The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
  • The offering will be made only by means of a prospectus supplement and an accompanying base prospectus.

Dicerna Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Wednesday, July 1, 2020 - 9:30pm

The stock options approved under the Inducement Grants were issued pursuant to Dicernas 2016 Inducement Plan and have an exercise price per share equal to $26.62, the fair market value on the grant date.

Key Points: 
  • The stock options approved under the Inducement Grants were issued pursuant to Dicernas 2016 Inducement Plan and have an exercise price per share equal to $26.62, the fair market value on the grant date.
  • The stock options have a 10-year term and are subject to the terms and conditions of the applicable stock option agreements.
  • The Company granted the stock options and RSUs as inducement materials to the new employees entering into employment with Dicerna Pharmaceuticals, Inc. in accordance with Nasdaq listing Rule 5635(c)(4).
  • This press release includes forward-looking statements pertaining to continued service of employees and future vesting of inducement grants.

Thinking about trading options or stock in FedEx Corp, Inovio Pharmaceuticals, Ford Motor, Boeing, or Plug Power?

Wednesday, July 1, 2020 - 2:31pm

NEW YORK, July 1, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for FDX, INO, F, BA, and PLUG.

Key Points: 
  • NEW YORK, July 1, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for FDX, INO, F, BA, and PLUG.
  • Click a link below then choose between in-depth options trade idea report or a stock score report.
  • Options Report Ideal trade ideas on up to seven different options trading strategies.
  • The report shows all vital aspects of each option trade idea for each stock.

Globus Maritime Announces Closing of Transaction

Wednesday, July 1, 2020 - 2:07pm

GLYFADA, Greece, July 01, 2020 (GLOBE NEWSWIRE) -- Globus Maritime Limited (the Company) (NASDAQ: GLBS) announced that on June 30, 2020 it closed the previously announced registered direct offering and concurrent private placement of warrants.

Key Points: 
  • GLYFADA, Greece, July 01, 2020 (GLOBE NEWSWIRE) -- Globus Maritime Limited (the Company) (NASDAQ: GLBS) announced that on June 30, 2020 it closed the previously announced registered direct offering and concurrent private placement of warrants.
  • Accordingly, you should not unduly rely on these forward-looking statements, which speak only as of the date of this communication.
  • Globus undertakes no obligation to publicly revise any forward-looking statement to reflect circumstances or events after the date of this communication or to reflect the occurrence of unanticipated events.
  • You should, however, review the factors and risks Globus describes in the reports it will file from time to time with the Securities and Exchange Commission after the date of this communication.